Cellosaurus SCC-3 (CVCL_1683)

Cell line name SCC-3
Synonyms SCC3
Accession CVCL_1683
Resource Identification Initiative To cite this cell line use: SCC-3 (RRID:CVCL_1683)
Comments Part of: MD Anderson Cell Lines Project.
Microsatellite instability: Stable (MSS) (Sanger).
Omics: Deep exome analysis.
Omics: Deep RNAseq analysis.
Omics: DNA methylation analysis.
Omics: Protein expression by reverse-phase protein arrays.
Omics: SNP array analysis.
Disease B-cell non-Hodgkin lymphoma (NCIt: C3457)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Female
Category Cancer cell line
STR profile Source(s): Cosmic-CLP; JCRB; PubMed=25877200

Markers:
AmelogeninX
CSF1PO12
D13S3178
D16S53912 (Cosmic-CLP; PubMed=25877200)
11,12 (JCRB)
D18S5113,18
D21S1131
D3S135815
D5S8189
D7S82011,12
D8S117911
FGA19
Penta D11,14
Penta E17,19
TH019
TPOX9,11
vWA16,17
Web pages http://tcpaportal.org/mclp/
Publications

PubMed=3095281; DOI=10.20772/cancersci1985.77.9_862
Kimura Y., Toki H., Okabe K.-I., Suzuki K., Hayakawa T., Miyamoto K.
Establishment and characterization of a monocytic cell line which expresses the interleukin-2 receptor.
Jpn. J. Cancer Res. 77:862-865(1986)

PubMed=25485619; DOI=10.1038/nbt.3080
Klijn C., Durinck S., Stawiski E.W., Haverty P.M., Jiang Z., Liu H., Degenhardt J., Mayba O., Gnad F., Liu J., Pau G., Reeder J., Cao Y., Mukhyala K., Selvaraj S.K., Yu M., Zynda G.J., Brauer M.J., Wu T.D., Gentleman R.C., Manning G., Yauch R.L., Bourgon R., Stokoe D., Modrusan Z., Neve R.M., de Sauvage F.J., Settleman J., Seshagiri S., Zhang Z.
A comprehensive transcriptional portrait of human cancer cell lines.
Nat. Biotechnol. 33:306-312(2015)

PubMed=27397505; DOI=10.1016/j.cell.2016.06.017
Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P., Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H., Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H., Deng X., Egan R.K., Liu Q., Mironenko T., Mitropoulos X., Richardson L., Wang J., Zhang T., Moran S., Sayols S., Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.
A landscape of pharmacogenomic interactions in cancer.
Cell 166:740-754(2016)

PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005
Li J., Zhao W., Akbani R., Liu W., Ju Z., Ling S., Vellano C.P., Roebuck P., Yu Q., Eterovic A.K., Byers L.A., Davies M.A., Deng W., Gopal Y.N.V., Chen G., von Euw E.M., Slamon D.J., Conklin D., Heymach J.V., Gazdar A.F., Minna J.D., Myers J.N., Lu Y., Mills G.B., Liang H.
Characterization of human cancer cell lines by reverse-phase protein arrays.
Cancer Cell 31:225-239(2017)

Cross-references
Cell line collections JCRB; JCRB0115
Cell line databases/resources Cosmic-CLP; 910930
GDSC; 910930
LINCS_LDP; LCL-1128
Ontologies EFO; EFO_0006484
Biological sample resources BioSample; SAMN03470797
BioSample; SAMN03472740
Chemistry resources ChEMBL-Cells; CHEMBL3308215
ChEMBL-Targets; CHEMBL2366081
Gene expression databases GEO; GSM827237
GEO; GSM1670410
Polymorphism and mutation databases Cosmic; 910930
Cosmic; 998750
Cosmic; 1037667
Cosmic; 1086352